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In man, rat, and mouse it has been shown that CD4+ T cellscan be divided into
two subpopulations on the basis oftheir reactivity with mAbs that recognize a re-
stricted number of members of the leukocyte common antigen (CD45) family of
glycoproteins (1-4). Assays ofT cell function carried out on the two subpopulations
have shown that this phenotypic heterogeneity is associated with a functional one
and data obtained in the three species, while not completely concordant, are sub-
stantially in agreement (5).
In the rat the mAb MRC OX-22, which binds to some of the higher molecular
mass forms ofCD45 (6) butnot to the low (180kD) molecular mass one, labels -70%
ofCD4+ T cells. Assays ofT cell function have shown that it is the MRC OX-22+
CD4+ T cells that proliferate most vigorously to allogeneic stimulator cells and to
T cell mitogens (7) and produce high levels of IL-2, whereas the MRC OX-22-
CD4+ cells provide the majority ofhelp for B cells in secondary immune responses,
both in vivo and in vitro (1, 7).
It has been the source ofmuch debate whether these two major subpopulations
ofCD4+ T cells represent reciprocal, nonoverlapping subsets ofmature cells with
distinct functions or that the subsets represent different stages ofT cell maturation.
In man, CD4+ Tcells isolated from umbilical cord blood do not contain the subset
that expresses the low molecular weight form of the CD45 antigen, whereas this
population is present in adult peripheral blood and contains within it those cells
that respond to recall antigens such as mumps virus and tetanus toxoid (2, 8). Fur-
thermore, on in vitro stimulation, CD4+ T cells expressing the higher molecular
mass forms ofCD45 change their phenotype and come to express only the 180-kD
form ofthe antigen, i.e., they acquire the characteristics ofthe subset ofTcells that
displayimmunological memory (9). These observations, while giving supportto the
view that the two subsets of CD4+ T cells are related by lineage, do not exclude
the possibility that CD4+ Tcells that respond to recall antigens derive from cells
ofa separate lineage that also expresses only the low molecular weight forms ofthe
CD45 antigen.
In our earlier work attempts were made to establish a lineage relationship be-
tween the MRC OX-22+ CD4+ (putative precursor) and MRC OX-22- CD4+
(product) subsets ofratT cellsbypriming ratswith allogeneicskin grafts and testing
the MRC OX-22- cells for alloreactivity in vitro. No evidence of T cell priming
couldbe obtainedintheseexperiments (7). Furthermore, adultthymectomycarried
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out to cut off the source of fresh precursors failed to demonstrate a decline in the
size of the putative precursor pool (7).
These experiments failed to support the view that the two subsets represented
different stages ofT cell maturation but theessentially negative nature of the results
made a definite conclusion impossible (7). Given these uncertainties and the lack
of a concensus view on the situation in man, further study of the relationship be-
tween the two subsets of CD4' T cells was clearly indicated.
Herein, we describe in vivo experiments designed specifically to establish the lin-
eage relationship between the two subsets of CD4' T cells.
Materials and Methods
Rats.
￿
The PVG.RTlc rats used were from the specific pathogen-free (SPF)1 unit of the
Medical Research Council Cellular Immunology Unit (Oxford, UK). Congenitally athymic
nude rats (PVG rnu/rnu) were obtained from Harlan Olac (Bicester, Oxon) and maintained
underSPF conditions throughout thecourse of the experiment. Irradiations were performed
using a "'Cs source at 94 rad/min (Gammacel; Atomic Energy of Canada Ltd., Kanata,
Ontario).
Preparation ofAdult Thymectomized, Lethally-irradiated, BoneMarrow-restoredRats (B Rats).
￿
PVG
rats were thymectomized at 6-8 wk of age. 2 wk later the animals were irradiated with two
600-rad doses ofy radiation 3 d apart, immediately after which, the animals were restored
with 10' T cell-depleted bone marrow cells from syngeneic donors.
Cells.
￿
Thoracic duct lymphocytes (TDL) were obtained by cannulation of the duct (10).
Cells from a pool of at least threePVG.RTlc rats were collected at 4'C overnight into flasks
containing PBS and 20 U/ml heparin.
Antibodies.
￿
The derivation of the mouse mAbs used in this work, viz W3/25 (anti-CD4)
(11), MRC OX-8 (anti-CD8) (11), MRC OX-12 (anti-ratkchain) (12), MRC OX-6 (anti-rat
class II) (13), MRC OX39 (anti-ratIL-2R) (14). MRC-OX-40(against a cell surface antigen
on CD4' Tcell blasts) (14). MRC OX-22 (1), and MRC OX-21 (15), have all been described
in the references given. Biotinylated mAbs were prepared as described (16).
Isolation ofSubsets ofLymphocytes.
￿
Subpopulations ofTDLwere prepared by negative selec-
tion using the rosetting technique (16), and cell fractionation was also carried out by means
ofaFAGS II (Becton Dickinson Immunocytometry Systems, Mountain View, CA)as previ-
ously described (7). For all fractionation procedures purity was assessed by FAGS analysis.
Reconstitution of T Cell-deficient Rats with TCellSubpopulations.
￿
Subpopulations ofTDLwere
injected intravenously into 6-10-wk-old nude or B rats. Animals also received 100-500 ug
of alum-precipitated OVA or dinitrophenyl-conjugated OVA (DNP-OVA) intraperitoneally
together with 109 killed Bordetella pertussis organisms at the time of T cell reconstitution.
FACSAnalysis of TDLfrom T Cell-ReplacedNude and B Rats.
￿
8-10 weeks after Tcell recon-
stitution 5 x 106 TDL were analyzed by two-color immunofluoresence on the FAGS as de-
scribed (16).
Binding Assay for Specific Antibody.
￿
Rat sera were diluted in PBS containing 0.2 17o BSA
(PBS/0.2 % BSA) and 50 ltl aliquots were assayed in duplicate for anti-OVA or antihapten
antibodies using a solid phase RIA, essentially as described in reference 1, except that the
developing antibody used was 1251-OX-12 F(ab')2 and for anti-OVA assays plates were pre-
pared by coatingwith 100 Al perwell of a 100-hg/ml solution of OVA in PBS containing 0.5
mm NaN3, at 4'C overnight.
Results
Phenotype of Lymphocytes Recoveredfrom T Cell-deficient Rats Reconstituted with Subsets
of CD4' TCells.
￿
When CD4+ T cells are injected into nude recipients, the donor
F. M. Powrie is in receipt of an Arthritis and Rheumatism Council research studentship.
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Tcells undergoextensive proliferation leading to a marked increase incellnumbers
(17, 18). This system was used to test the ability of the MRC OX-22' and MRC
OX-22 - subsets ofCD4' Tcells to expand in vivo and in particular to determine
whetherthe progeny ofthe MRC OX-22' CD4' inoculum retained the donor cell
phenotype or became MRC OX-22 - CD4*.
Irrespective o£whether nude or B rats were used as recipients, Tcell subsets un-
derwent a 100-1,000-fold expansion in the recipient animals asjudged by the fre-
quency of T cells in thoracic duct lymph (Table I). In the case ofthe MRC 0X-
22* CD4' T cell inoculum, the recipients were restored to near normal CD4' T
cell levels. However, these animals were far from normal in that there were very
few detectable MRC OX-22+ CD4' Tcells (Table I). The great majority ofCD4'
T cells in these animals were of the MRC OX-22- phenotype. That these MRC
OX-22- CD4' T cells derived from the expansion ofthe MRC OX22* CD4' cells
and not from a very minor contamination ofMRC OX-22- CD4' Tcells is sup-
ported by the fact that TDL from rats given much larger doses of purified MRC
TABLE I
Phenotype of TDLfrom T Cell-replaced B Rats or Athymic Rats
8-10 wk after Reconstitution
CD4* T cells were isolated from PVG TDL by removing MRC OX-8+, MRC OX-6+, and
MRC OX-12+ cells by rosette depletion as described in reference 7; recovered cells were
then kept on ice at 4°C or labeled with MRC OX-22 antibody and sorted on the FRCS
into positive and negative fractions. Purities of sorted cells were >98 % for both populations.
T cell-deficient rats were reconstituted with 1-5 x 106 fractionated PVG CD4' Tcells. 8-
10 wk later the recipients were cannulated and the TDL collected overnight were pheno-
typed by two-color immunolluorescence on a FAGS, using biotinylated W3/25 mAb in com-
bination with other mAbs.
Where pairs of numbers are given, the first refers to data from B rats and the second from
nudes. Data are the mean value obtained from three animals taken from two experiments.
Reaction with MRC OX-21 mAb that binds to a component of human complement, but
not rat tissues, was used as a negative control, and in all cases values obtained were <0.6%.
Ranges are not shown as they were within 10% of the mean value for all determinations.
The range of TDL output in 18 h is given in parenthesis: B rats reconstituted with; CD4*
T cells (1 .0-3.3 x 108), MRC OX-22* CD4' T cells (0.43-1 .98 x 106), MRC OX-22-
CD4* T cells (1 .34-1 .76 x 108), and unreconstituted B rats (0.2-2.0 x 108). Nude rats
reconstituted with: CD4* T cells (1 .1-2.7 x 108), MRC OX-22* CD4' T cells (0.6-2.3
x 108), MRC OX-22- CD4' T cells (1.9-3.3 x 108), and unreconstituted nude rats
(2.3-4.95 x 107). Normal PVG rats gave cell yields in the range, 2-3.8 x 108. As the above
data indicate some of the experimental groups showed large variations in TDL output but
the results of several independent experiments revealed that the surface phenotype of the
TDL obtained was insensitive to the dose of the T cell inocula or the TDL output.
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T cells injected CD4'
CD4'
OX22-
Percent positive cells (of
CD4* CD4*
0X22' IL2R*
the total)
CD4*
OX40' sIg* 0X8'
1-5 x 106
CD4* 25,21' 21, 20 3, 2 .7 7, 10 ND, 14 74, 67 2, 2
1-5 x 106
CD4* OX-22+ 41, 48 38, 45 3, 1 .3 12, 23 22, 37 56, 43 2, 2
1--5 x 106
CD4* OX-22- 17, 11 14, 10.5 3, 1 .6 3, 6 3, 6 82, 79 2, 3
Nude or B rat 5, 3 5, 2 1, 1 1, 1 1, 1 .4 90, 83 2, 2
Normal PVG 39 14 23 1 1 51 7656
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OX-22- cells contained a lower frequency of T cells than did the recipients of the
MRC OX-22' T cell subset (Table I). In fact, the MRC OX-22- T cell population
expanded in vivo to a similar level to that found in normal TDL, i.e., N12%. It is
known that the expression of the MRC OX-22 epitope is lost on T cell activation
in vitro (14), but it hasnot been shown whetherit is reexpressed when T cells return
to a resting state. These in vivo data confirmed the in vitro results showing loss of
the epitope on T cell activation but also showed that the antigen is not reexpressed
when T cells are no longer activated. Some of the CD4' T cells recovered from
nude rats (25%) given MRC OX-22+ CD4' T cells had reverted to a resting state,
asindicated bythe fact that they did not express IL-2-Rsor the MRC OX-40 deter-
minant (a CD4' blast antigen [14]) but they remained phenotypically MRC 0X-
22- CD4'. B rats injected with MRC OX-22+ CD4' T cells had an even higher
frequency of MRC OX-22- CD4' T cells with the characteristics of resting cells
(50%).
Phenotype ofthe TCell Reactive in Primary Immune Responses In Viva
￿
Immunization
ofnuderats withDNP-OVA atthe timeofT cellreconstitution resulted in significant
antihapten antibody responses in the sera of animals given CD4' T cells or the
MRC OX-22+ fraction thereof (Fig. 1). The MRC OX-22- CD4' reconstituted
animals failed to make a response above that ofthe unreconstituted nude negative
control. Titration ofsera obtained 20 d later gave similar results (data not shown).
Inthisexperiment the dose ofT cells given was in physiological ratios (i.e., approxi-
mately three times as many MRC OX-22' cells as MRC OX-22- cells). In a second
experiment using B rats asTcell recipients, equal T celldoses were given. Measure-
ments ofthe anti-OVA antibody response at 21 d (not shown) and 40 d (Fig. 2) also
showed that it was only the recipients ofMRC OX-22' CD4' orunseparated CD4'
T cells that produced antibody.
Previous data from this laboratory, obtained using adoptive transfer into acutely
preirradiated recipients, have shown that T cells that provide B cell help for sec-
ondary immune responses to haptenated protein are of the MRC OX-22- CD4'
phenotype(1). In contrast, these newresults, derived from chronicallyTcell-deficient
hosts, show that it is T cells that belong to the MRC OX-22+ CD4' population
that provide help for a primary antibody response to a soluble antigen in vivo. To
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FIGURE 1 .
￿
Primary antihapten antibody response in
T cell-reconstituted nude rats. CD4' T cellswere iso-
lated from PVG TDL and separated into MRC 0X-
22' and MRCOX-22- fractions as described in Table
I. Nude rats were reconstituted with 5 x 106MRC 0X-
22' CD4' (n = 3), 5 x 106 CD4' (n = 3), or 1.5 x
106 MRCOX-22- CD4' (n = 2) Tcells. Twoanimals
were not givencells. At this time alloftheanimalswere
immunized with 500 F+g of DNP-OVA, as described in
Materials and Methods. The data represent the mean
valueofduplicatedeterminations of the antihapten an-
tibody, as assessed by asolidphaseRIAon DNP-BGG-
coated plates, in the pooled sera of each experimental
group, at 14 din theresponse. Theserawere also titrated
individually and the range of values was shown to lie
within 5% of the mean value for all points in all ex-
perimental groups. Purities ofseparated CD4' Tcells
were >98%.SERUM CONCENTRATION%
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ensure that the MRC OX-22- CD4+ T cells were not incapable of responding in
this latter system, a test was made of the ability of these cells to provide help for
secondary immune responses.
B rats were reconstituted with CD4+ T cell subsets obtained from primed donors
and challenged with specific antigen at the time of T cell reconstitution. Table II
shows thatboth T cell subsetsprovided helpfor antihapten antibody responses when
these were assayed 28 d later, illustrating that MRC OX-22- T cells were perfectly
capable ofproviding help for a secondary immune response in T-deficient rats. It
is notable that the MRC OX-22' T cells provided equally good help, which sug-
gests thatonprimingoftheTcelldonors notall oftheantigen-reactive T cells moved
into the memory pool. This point will be pursued further in the discussion.
MRC OX--22- Memory T Cells Derive from MRC OX-22+ Naive Precursors.
￿
Given
that memory T cells are ofthe MRC OX-22- phenotype, the question arises as to
whether these cells originate from MRC OX-22+ CD4+ precursor cells, the popu-
lation inwhichprimaryT helper reactivity resides, or whetherthey derive as a sepa-
rate lineage, from an MRC OX-22- CD4+ precursor. To address this point, B rats,
reconstituted several months earlier with subpopulations of CD4+ T cells from
TABLE II
Secondary Antihapten Antibody Responses in B Rats Reconstituted with
Subsets of CD4' T Cellsfrom Antigen-primed Donors
FIGURE 2.
￿
Primaryanti-OVA antibody response
in B rats reconstituted with subpopulations of
CD4' T cells. 2 x 106 MRC OX-22' or MRC
OX-22- fractions of CD4' TDL, purified as
outlined in TableI, were injected into syngeneic
B rat recipients. Control rats received 2 x 106
CD4+ T cells, or were notreconstituted at all.
At thetime of cell transfer allrecipients were im-
munizedwith 100 ftgofOVA. Theanti-OVA re-
sponse wasdetermined 40 d laterby solidphase
RIAon OVA-coated plates. Purities forthesepa-
rated CD4' T cells were >997c. Theresults rep-
resent meanswith ranges forthreerats pergroup
for Tcell-reconstituted animals and tworats per
group for the unreconstituted animals.
Percent relative antibody titer*
CD4' T cells were isolated from rats primed 8 wk earlier with 100lag alum-
precipitated DNP-OVA, and separated into MRC OX-22' and MRC
OX-22- fractions as described in TableI. B rats were reconstituted with 1 .5
x 106T cellsand immunized with 100 tagDNP-OVA. Sera were assayed28 d
later forantihapten antibodies by asolidphaseRIAon DNP-BGG-coated plates.
* The mean antihapten antibody titers areexpressedas apercentage of thecon-
trol response, produced by unfractionated CD4' T cells. There were two
animals per group. Purities of separated CD4' T cells were >98% .
1.5 x 106 CD4' T cells 100
1.5 x 106 MRC OX-22' CD4' T cells 102.5
1 .5 x 106 MRC OX-22- CD4' T cells 87.5
Unreconstituted 12.5658
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normal donors, and immunized at the time of cell transfer, were challenged with
the same antigen to see whether an anamnestic response could be elicited.
Several of the animals used to generate the primary anti-OVA responses shown
in Fig. 2 were kept for 5 mo, at which time their anti-OVA titers were measured.
The MRC OX-22+ CD4+ and unseparated CD4+ T cell-reconstituted animals still
showed good antibody titers (Table III), whereas the MRC OX-22 - CD4+ T cell-
reconstituted animals still failed to show a significant antibody titer. Challenge with
antigen atthis timeled toaconsiderableincrease inantibodytiterinanimal's number
4 (MRC OX-22' T cell reconstituted) and number 3 (CD4+ T cell reconstituted).
A smaller increase in antibody titer was seen in animal number 8 an MRC 0X-
22 - T cell-reconstituted animal (Table III). This latter finding may represent
antigen-reactive T cells that were originally MRC OX-22+ and present as a small
contamination in the original T cell inoculum which, after 5 mo expansion in vivo,
could provide some B cell help. It is notable that the secondary anti-OVA titerfrom
this MRC OX-22- T cell-reconstituted animal is 100-fold lower than the secondary
response evoked in the MRC OX-22' T cell-reconstituted animal. This was not
the case with the other MRC OX-22 - CD4+ T cell-reconstituted animal, number
9, orthe unreconstituted negative controlanimalsnumbers 10 and 11, which showed
no increase in antibody titer upon antigenic challenge, suggesting there were no
antigen-reactive T cells in these animals.
A further experiment showed that 107 TDL obtained from a B rat donor recon-
stituted 12 wk earlier with MRC OX-22 + CD4+ T cells (one ofthe animals from
the experiment describedin Fig. 2, butnot used in that described in TableIII) could
adoptively transfer B cell help for anti-OVA responses into sublethally irradiated
syngeneic recipients, whereas TDL obtained at this time from animal number 9
(Table III) could not (Fig. 3). As this acute adoptive transfer system requires that,
in order to get an antibody response to soluble antigen in the recipient animals,
the donor lymphocytes must be primed (1), one can conclude that MRC OX-22-
TABLE III
Induction of Secondary Immune Responses in B Rats Reconstituted with
Subsets of CD4+ T cells
B rats reconstituted and immunized as outlined in Fig. 2 were kept for 5 mo, at which time
their sera were assayed for anti-OVA antibodies. They were then challenged with 100 ug OVA
intravenously and their sera were titrated 7 d later. Serial dilutions were assayed in duplicate.
Data represent the titer expressed as a percentage ofthe value obtained with a reference anti-
serum to OVA raised in PVG rats.
Animal
No . Cell dose
Primary
titer
Secondary
titer
Increase (primary
to secondary)
2 2 x 106 CD4' T cells 40 80 2 x
3 2 x 106 CD4' T cells 16 312 .5 20x
4 2 x 106 OX-22' CD4' T cells 44 704 16x
8 2 x 106 OX-22- CD4' T cells 1 .5 7 .5 5 x
9 2 x 106 OX-22- CD4* T cells <1 .5 <1 .5 0
10 Unreconstituted <1 .5 <1 .5 0
11 Unreconstituted <1 .5 <1 .5 0POWRIE AND MASON
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FIGURE 3.
￿
Adoptive transfer ofasecondaryanti-
OVAantibody response with cells that originated
from the OX-22' CD4' T cell population. 10'
TDLwere obtained from B ratdonors that had
been T cell reconstituted and immunized 3 mo
earlier as described in Fig. 2. These cells were
adoptively transferred into sublethally irradiated
(750 rad) syngeneic recipients. Animals 1 and 2
received TDLobtained from adonoranimal that
hadoriginally received MRCOX-22' CD4' T
cells, whereasanimals 3and4 received TDL from
an MRC OX-22- CD4' Tcell-restored donor.
At thetime ofTcell transfer, the recipients were
immunizedwith 100,ug OVAintravenously. Sera
obtained 9dlaterwere titrated foranti-OVA an-
tibody usinga solid phase RIA. Data represent
duplicate determinations. The negative control
serum used was normal PVG serum.
CD4' memory T cells active in secondary responses, like those responsible for B cell
help in primary responses, derived from Tcells that belong to the MRC OX-22'
CD4+ population, and not from a putative separate cell lineage that is MRC
OX-22- before exposure to antigen.
Discussion
The in vivo T cell reconstitution studies described here demonstrate a precursor-
product relationship between MRC OX-22+ and MRC OX-22- subsets of CD4+
T cells involved in the provision ofhelper activity for B cells. The experimentsshow
that in assays ofprimary B cell help, the MRC OX-22' CD4+ T cells were active
in contrast to assays of secondary help, in which the MRC OX-22- CD4+ T cells
were the most potent (1). Further, the antigen-specific memory Tcells in the MRC
OX-22- CD4+ population derive from MRC-OX-22+ CD4+ precursors.
Consistent with this lineage relationship between the two subsets ofCD4' T cells
is the finding that nude or T cell-deficient B rats reconstituted with CD4' or MRC
OX-22' CD4' T cells contain, 8-10 wk after T cell reconstitution, CD4' cells that
are virtually all MRC OX-22-, even though the animals have reconstituted to near
normal CD4' T cell levels. The stimulus for this expansion of the CD4' T cells
is unknown. It may be that it all derives from environmental antigens to which the
T cell-deficient recipient animals have no immunity before cell transfer. Thefinding
that rats primed to a specific antigen had antigen-reactive Tcells in both the MRC
OX-22- CD4' and the MRC OX22' CD4' subsets indicates that the naive Tcell
pool is not depleted ofantigen-reactive cells on priming. It follows that normal rats
may be expected tohave bothmemory TcellsandnaiveTcells capable ofresponding
to environmental antigens. However, this hypothesis doesnotexplain thehigher fre-
quency of CD4' T cells in nude or B rats given MRC OX-22' CD4' cells com-
pared with recipients ofMRC OX-22- CD4' T cell inocula. Alternatively, it may
bethat an antigen-independentexpansion occurs, analogousto theautologous MLC
in vitro (19), and that this spontaneous activation is inhibited in normal animals
by some homeostatic mechanism. Such a mechanism may be expected to maintain
Tcell numbers at their physiological levels and prevent the improperly regulated660
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T cell expansion that is observed in T cell-deficient animals injected with relatively
low doses ofsyngeneic T cells. This interestingproblem oflymphocyte homeostasis
requires further study.
There is no evidence to suggest that the MRC OX-22 epitope is reexpressed in
the periphery after it has been lost after T cell activation. Indeed, the data suggest
the opposite, that the antigen-reactive daughter cells are MRC OX-22- even when
they revert to a resting phase.
Despite the demonstration that MRC OX-22- CD4' peripheral T cells that pro-
vide helper activity for B cellsderive from MRC OX-22+ CD4' precursors, acqui-
sition ofthe MRC OX-22- phenotype does not simply reflect a numerical expan-
sion of naive cells on encounter with antigen. As stated in the introduction, on
activation by T cell mitogen, MRC OX-22+ CD4' T cells produce much more IL-2
than do cells of the MRC-OX-22- phenotype and similar results have been found
with mouse T cell subsets (4). The data from experiments in man are not clear in
this regard. It hasbeen reported that comparable levels ofIL-2 can be elicited from
CD4' T cells of naive and memory phenotype (20) but the contrary result, that
on activation, naive Tcells produce much more IL-2 than memory cells, has also
been found (21). Several explanations may be advanced for the difference in IL-2
releasebetween thetwo subsetsofratTcells. Itmaybethathighlevels ofIL-2 produc-
tion are characteristic of CD4' T cells only on their first encounter with antigen
and that the progeny of these high producers become MRC OX-22" CD4' cells
that haveadiminished capacity to synthesize thislymphokine. As thepresent studies
have been carriedout on uncloned populations, it is not clear whether the lowlevels
ofIL-2 found in activated cultures ofMRC OX-22- CD4+ T cells reflects a low
frequencyofIL-2 producers or alowleveloflymphokine production per cell. Studies
on mouse T cell clones have shown that some produce IL-2 while others produce
IL-4 (22), and itmaybethata similar heterogeneityoflymphokine production occurs
with in vitro stimulation of MRC OX-22- CD4' T cells obtained directly from
normal animals. If so, then it must be concluded that IL-2 producers are not well
represented in the MRC OX-22- CD4' subset. Further discussion ofthis impor-
tant point is complicated by the fact that the human T cell clones apparently fail
to fall intotwo simple categories as described inthe mouse (23), in that the majority
produce IL-2, and it may be that activated MRC OX-22- Tcells produce varying
amounts of IL-2 but that few, if any, produce none.
An alternative explanation for the difference in the level of IL-2 production be-
tween the two subsets ofCD4' T cells is that the MRC OX-22+ subset is itself het-
erogeneous, in that cells that produce highlevels ofIL-2 on primary activation may
retain their MRC OX-22+ phenotype (or fail to become memory cells at all) while
those MRC OX-22' CD4' cells that, on activation, provide helper activity for B
cells change their phenotype to MRC OX-22- after their primary encounter with
antigen. However, the hypothesis that the MRC OX-22+ CD4' subset contains
memory cells for high IL-2 production is not consistent with the observation that
in vitro responses to recall antigen cannot be elicited from human T cells that are
almost certainly homologous to the MRC OX-22' CD4' subset in the rat (2), and
similarly, rat T celllines specific for guinea pig myelin basic protein (J. Sedgewick,
personal communication) and clones responding to other soluble proteins and al-
logeneic stimulator cells (24) have been shown to have the MRC OX-22- pheno-POWRIE AND MASON
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type. Consequently, we favor the alternative hypothesis advanced earlier, namely
that high levels of IL-2 production are characteristic only of naive CD4' T cells
on their first encounter with antigen and that memory cells produce much less of
this lymphokine on activation, at least when these cells are obtained from rats kept
in SPF conditions.
If diminished IL-2 production is indeed a characteristic of memory T cells, then
the stage in T cell maturation at which this event occurs remains to be precisely
defined. Murine T cells that have been deprived of antigenic stimulation for 48 h
after primary in vitro activation do not produce significantly lower levels of IL-2
on secondary exposure to antigen (25), so the change in lymphokine production
is apparently not acute. It may be that recurrent stimulation ofT cells at relatively
short intervals can give sustained IL-2 production at high levels, as has been reported
for some T cell clones (22).
Summary
CD4+ T cells in the rat can be divided into two nonoverlapping subsets by their
reactivity with the mAb MRC OX-22, which binds some ofthe high molecular weight
forms of the CD45 antigen.
The lineage relationship between subsets of CD4+ T cells expression different
forms ofCD45 has been a controversial issue for some time. Experiments described
in this paper address this question using in vivo assays of T cell reactivity.
Analysis of primary antibody responses in vivo show that it is MRC OX-22+
CD4+ T cells that are active in these assays, whereas antigen-primed T cells that
provide helper activity for secondary antibody responses in vivo have the MRC 0X-
22- CD4+ phenotype. It is demonstrated that these memory T cells derive from
MRC OX-22' CD4+ T cell precursors and not from a putative separate lineage.
It is concluded that with respect to the provision of help for B cells, MRC 0X-
22 + CD4+ T cells are precursors of memory cells with the phenotype MRC 0X-
22 - CD4+.
Our thanks are due to Steve Simmonds for expert technical assistance and to Reg Boone
for running the cell sorter.
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